Director, Managed Healthcare Medical Scientist

Remote

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Pharmaceutical, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a strong understanding of muscle biology, cardiovascular diseases, and the pharmaceutical industry. A proven track record in managed care, health economics, and health policy is essential, along with the ability to engage in peer-to-peer scientific discussions with key decision-makers in organizations such as MCOs, SPs, PBMs, and IDNs. Experience in developing and executing medical affairs plans is also required.

Responsibilities

The Director, Managed Healthcare Medical Scientist will identify and engage with key national and regional healthcare decision-makers, fostering professional relationships to explore research and educational partnerships. Responsibilities include communicating scientific and clinical value, documenting insights to inform strategy, and identifying data gaps. The role involves serving as a medical lead within account teams, collaborating across departments, and representing the company at scientific conferences and advisory boards.

Skills

Managed Healthcare

Medical Science Liaison

Clinical Value

Health Economics

Managed Care

Health Policy

Cardiovascular Disease

Neuromuscular Disease

Muscle Biology

Drug Development

Scientific Communication

Key Opinion Leader Engagement

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free